MiR-22 is frequently downregulated in medulloblastomas and inhibits cell proliferation via the novel target papst1

Brain Pathology

Volumn 24, Issue 6, 2014, Pages 568-583

  Xu, Qing Fu ^a   Pan, Ya Wen ^a   Li, Li Chao ^b   Zhou, Zheng ^a   Huang, Qi Lin ^a   Pang, Jesse Chung Sean ^b   Zhu, Xiao Peng ^a   Ren, Yong ^c   Yang, Hui ^a   Ohgaki, Hiroko ^d   Lv, Sheng Qing ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b LANZHOU UNIVERSITY   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

apoptosis; cell proliferation; medulloblastoma; miR 22; PAPST1

Indexed keywords

CASPASE 3; LENTIVIRUS VECTOR; MESSENGER RNA; MICRORNA 22; ANION TRANSPORT PROTEIN; CARRIER PROTEIN; MICRORNA; MIRN22 MICRORNA, HUMAN; PAPST1 PROTEIN, MOUSE; SLC35B2 PROTEIN, HUMAN;

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUCIFERASE ASSAY; MALE; MEDULLOBLASTOMA; MEDULLOBLASTOMA CELL LINE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PAPST1 GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION; WESTERN BLOTTING; ANIMAL; CANCER TRANSPLANTATION; CEREBELLUM; CEREBELLUM TUMOR; INFANT; METABOLISM; MIDDLE AGED; NUDE MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; TUMOR CELL LINE; YOUNG ADULT;

ADOLESCENT; ADULT; ANIMALS; ANION TRANSPORT PROTEINS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CEREBELLAR NEOPLASMS; CEREBELLUM; CHILD; CHILD, PRESCHOOL; DOWN-REGULATION; HUMANS; INFANT; MEDULLOBLASTOMA; MEMBRANE TRANSPORT PROTEINS; MICE, NUDE; MICRORNAS; MIDDLE AGED; NEOPLASM TRANSPLANTATION; YOUNG ADULT;

EID: 84912084752     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12136     Document Type: Article

References (53)

1. Andolfo I, Liguori L, De Antonellis P, Cusanelli E, Marinaro F, Pistollato F, et al (2012) The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma. Neuro Oncol 14: 596-612.
2. Bai AH, Milde T, Remke M, Rolli CG, Hielscher T, Cho YJ, et al (2012) MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma. Acta Neuropathol 123: 529-538.
3. Bartel DP, (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
4. Berenguer J, Herrera A, Vuolo L, Torroba B, Llorens F, Sumoy L, Pons S, (2013) MicroRNA 22 regulates cell cycle length in cerebellar granular neuron precursors. Mol Cell Biol 33: 2706-2717.
5. Bonzon C, Fan H, (1999) Moloney murine leukemia virus-induced preleukemic thymic atrophy and enhanced thymocyte apoptosis correlate with disease pathogenicity. J Virol 73: 2434-2441.
6. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, et al (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101: 2999-3004.
7. de Bont JM, Packer RJ, Michiels EM, den Boer ML, Pieters R, (2008) Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective. Neuro Oncol 10: 1040-1060.
8. Ferretti E, De Smaele E, Miele E, Laneve P, Po A, Pelloni M, et al (2008) Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells. EMBO J 27: 2616-2627.
9. Ferretti E, De Smaele E, Po A, Di Marcotullio L, Tosi E, Espinola MS, et al (2009) MicroRNA profiling in human medulloblastoma. Int J Cancer 124: 568-577.
10. Franchina T, Amodeo V, Bronte G, Savio G, Ricciardi GR, Picciotto M, et al (2014) Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non-small cell lung cancer. J Cell Physiol 229: 97-99.
11. Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CM, (2006) MicroRNA expression and function in cancer. Trends Mol Med 12: 580-587.
12. Gibson P, Tong Y, Robinson G, Thompson MC, Currle DS, Eden C, et al (2010) Subtypes of medulloblastoma have distinct developmental origins. Nature 468: 1095-1099.
13. Gilbertson RJ, (2004) Medulloblastoma: signalling a change in treatment. Lancet Oncol 5: 209-218.
14. Hobert O, (2008) Gene regulation by transcription factors and microRNAs. Science 319: 1785-1786.
15. Kamiyama S, Ichimiya T, Ikehara Y, Takase T, Fujimoto I, Suda T, et al (2011) Expression and the role of 3'-phosphoadenosine 5'-phosphosulfate transporters in human colorectal carcinoma. Glycobiology 21: 235-246.
16. Kamiyama S, Suda T, Ueda R, Suzuki M, Okubo R, Kikuchi N, et al (2003) Molecular cloning and identification of 3'-phosphoadenosine 5'-phosphosulfate transporter. J Biol Chem 278: 25958-25963.
17. Konishi H, Sugiyama M, Mizuno K, Saito H, Yatabe Y, Takahashi T, Osada H, (2003) Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer. Oncogene 22: 1892-1905.
18. Kool M, Korshunov A, Remke M, Jones DT, Schlanstein M, Northcott PA, et al (2012) Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, group 3, and group 4 medulloblastomas. Acta Neuropathol 123: 473-484.
19. Li J, Liang S, Yu H, Zhang J, Ma D, Lu X, (2010) An inhibitory effect of miR-22 on cell migration and invasion in ovarian cancer. Gynecol Oncol 119: 543-548.
20. Li X, Liu J, Zhou R, Huang S, Chen XM, (2010) Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation. Br J Haematol 148: 69-79.
21. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408.
22. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, (2007) WHO classification of tumours of the central nervous system. In: World Health Organization classification of tumours, 4th edn., F Giangaspero, CG Eberhart, H Haapasalo, T Pietsch, OD Wiestler, DW Ellison, (eds), pp. 132-140. International Agency for Research on Cancer: Lyon.
23. Lv SQ, Kim YH, Giulio F, Shalaby T, Nobusawa S, Yang H, et al (2012) Genetic alterations in microRNAs in medulloblastomas. Brain Pathol 22: 230-239.
24. Massimino M, Giangaspero F, Garrè ML, Gandola L, Poggi G, Biassoni V, et al (2011) Childhood medulloblastoma. Crit Rev Oncol Hematol 79: 65-83.
25. McDonald JD, Daneshvar L, Willert JR, Matsumura K, Waldman F, Cogen PH, (1994) Physical mapping of chromosome 17p13.3 in the region of a putative tumor suppressor gene important in medulloblastoma. Genomics 23: 229-232.
26. Nakayama F, Umeda S, Ichimiya T, Kamiyama S, Hazawa M, Yasuda T, et al (2013) Sulfation of keratan sulfate proteoglycan reduces radiation-induced apoptosis in human Burkitt's lymphoma cell lines. FEBS Lett 587: 231-237.
27. Nishimura M, Suzuki S, Satoh T, Naito S, (2009) Tissue-specific mRNA expression profiles of human solute carrier 35 transporters. Drug Metab Pharmacokinet 24: 91-99.
28. Pfister S, Remke M, Benner A, Mendrzyk F, Toedt G, Felsberg J, et al (2009) Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. J Clin Oncol 27: 1627-1636.
29. Pfister S, Remke M, Toedt G, Werft W, Benner A, Mendrzyk F, et al (2007) Supratentorial primitive neuroectodermal tumors of the central nervous system frequently harbor deletions of the CDKN2A locus and other genomic aberrations distinct from medulloblastomas. Genes Chromosomes Cancer 46: 839-851.
30. Phillips NJ, Zeigler MR, Deaven LL, (1996) A cDNA from the ovarian cancer critical region of deletion on chromosome 17p13.3. Cancer Lett 102: 85-90.
31. Pierson J, Hostager B, Fan R, Vibhakar R, (2008) Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma. J Neurooncol 90: 1-7.
32. Plisiecka-Hałasa J, Dansonka-Mieszkowska A, Kraszewska E, Dańska-Bidzińska A, Kupryjańczyk J, (2008) Loss of heterozygosity, microsatellite instability and TP53 gene status in ovarian carcinomas. Anticancer Res 28: 989-996.
33. Prydz K, Dalen KT, (2000) Synthesis and sorting of proteoglycans. J Cell Sci 113 (Pt 2): 193-205.
34. Ray A, Ho M, Ma J, Parkes RK, Mainprize TG, Ueda S, et al (2004) A clinicobiological model predicting survival in medulloblastoma. Clin Cancer Res 10: 7613-7620.
35. Roncuzzi L, Brognara I, Baiocchi D, Amadori D, Gasperi-Campani A, (2005) Loss of heterozygosity at 17p13.3-ter, distal to TP53, correlates with negative hormonal phenotype in sporadic breast cancer. Oncol Rep 14: 471-474.
36. Sasaki N, Hirano T, Ichimiya T, Wakao M, Hirano K, Kinoshita-Toyoda A, et al (2009) The 3'-phosphoadenosine 5'-phosphosulfate transporters, PAPST1 and 2, contribute to the maintenance and differentiation of mouse embryonic stem cells. PLoS One 4: e8262.
37. Scheurlen WG, Krauss J, Kühl J, (1995) No preferential loss of one parental allele of chromosome 17p13.3 in childhood medulloblastoma. Int J Cancer 63: 372-374.
38. Spiller SE, Logsdon NJ, Deckard LA, Sontheimer H, (2011) Inhibition of nuclear factor kappa-B signaling reduces growth in medulloblastoma in vivo. BMC Cancer 11: 136.
39. Spina R, Filocamo G, Iaccino E, Scicchitano S, Lupia M, Chiarella E, et al (2013) Critical role of zinc finger protein 521 in the control of growth, clonogenicity and tumorigenic potential of medulloblastoma cells. Oncotarget 4: 1280-1292.
40. Sun M, Estrov Z, Ji Y, Coombes KR, Harris DH, Kurzrock R, (2008) Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol Cancer Ther 7: 464-473.
41. Tsuchiya N, Izumiya M, Ogata-Kawata H, Okamoto K, Fujiwara Y, Nakai M, et al (2011) Tumor suppressor miR-22 determines p53-dependent cellular fate through post-transcriptional regulation of p21. Cancer Res 71: 4628-4639.
42. Vidal DO, Marques MM, Lopes LF, Reis RM, (2013) The role of microRNAs in medulloblastoma. Pediatr Hematol Oncol 30: 367-378.
43. Wade A, Robinson AE, Engler JR, Petritsch C, James CD, Phillips JJ, (2013) Proteoglycans and their roles in brain cancer. FEBS J 280: 2399-2417.
44. Weeraratne SD, Amani V, Teider N, Pierre-Francois J, Winter D, Kye MJ, et al (2012) Pleiotropic effects of miR-183 96 182 converge to regulate cell survival, proliferation and migration in medulloblastoma. Acta Neuropathol 123: 539-552.
45. Woods K, Thomson JM, Hammond SM, (2007) Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. J Biol Chem 282: 2130-2134.
46. Xiong J, (2012) Emerging roles of microRNA-22 in human disease and normal physiology. Curr Mol Med 12: 247-258.
47. Xiong J, Yu D, Wei N, Fu H, Cai T, Huang Y, et al (2010) An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples. FEBS J 277: 1684-1694.
48. Xu D, Takeshita F, Hino Y, Fukunaga S, Kudo Y, Tamaki A, et al (2011) miR-22 represses cancer progression by inducing cellular senescence. J Cell Biol 193: 409-424.
49. Yamakuchi M, Yagi S, Ito T, Lowenstein CJ, (2011) MicroRNA-22 regulates hypoxia signaling in colon cancer cells. PLoS One 6: e20291.
50. Yokota N, Aruga J, Takai S, Yamada K, Hamazaki M, Iwase T, et al (1996) Predominant expression of human zic in cerebellar granule cell lineage and medulloblastoma. Cancer Res 56: 377-383.
51. Zhang G, Xia S, Tian H, Liu Z, Zhou T, (2012) Clinical significance of miR-22 expression in patients with colorectal cancer. Med Oncol 29: 3108-3112.
52. Zhang J, Yang Y, Yang T, Liu Y, Li A, Fu S, et al (2010) microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity. Br J Cancer 103: 1215-1220.
53. Zhao X, He M, Wan D, Ye Y, He Y, Han L, et al (2003) The minimum LOH region defined on chromosome 17p13.3 in human hepatocellular carcinoma with gene content analysis. Cancer Lett 190: 221-232.